Cargando…
Effect of intravenous immunoglobulin therapy on anti-NT5C1A antibody-positive inclusion body myositis after successful treatment of hepatitis C: A case report
Inclusion body myositis (IBM) is the commonest idiopathic inflammatory myopathy of older persons. Pathophysiological mechanism of IBM remains unknown; however, an association of IBM with chronic hepatitis C virus (HCV) infection and serum autoantibodies against skeletal muscle protein 5′-nucleotidas...
Autores principales: | Takamiya, Motonori, Takahashi, Yoshiaki, Morimoto, Mizuki, Morimoto, Nobutoshi, Yamashita, Satoshi, Abe, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732757/ https://www.ncbi.nlm.nih.gov/pubmed/31517073 http://dx.doi.org/10.1016/j.ensci.2019.100204 |
Ejemplares similares
-
A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure
por: Morimoto, Nobutoshi, et al.
Publicado: (2020) -
Spreading brain lesions in a familial Creutzfeldt-Jakob disease with V180I mutation over 4 years
por: Deguchi, Kentaro, et al.
Publicado: (2012) -
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
por: Amlani, Adam, et al.
Publicado: (2019) -
A Case of Oculopharyngeal Muscular Dystrophy Caused by a Novel PABPN1 c.34G > T (p.Gly12Trp) Point Mutation without Polyalanine Expansion
por: Takahashi, Yoshiaki, et al.
Publicado: (2023) -
Cerebral syphilitic gumma mimicking a brain tumor that enlarged temporarily after commencing antibiotic treatment
por: Takahashi, Yoshiaki, et al.
Publicado: (2022)